bioRxivPharmacology & Toxicology
Reversible silencing of endogenous receptors in intact brain tissue using two-photon pharmacology
S. Pittolo, H. Lee, A. Llado, S. Tosi, M. Bosch, L. Bardia, X. Gomez-Santacana, A. Llebaria, E. Soriano, J. Colombelli, K. E. Poskanzer, G. Perea, P. Gorostiza
Abstract
The physiological activity of proteins is often studied with loss-of-function genetic approaches, but the corresponding phenotypes develop slowly and can be confounding. Photopharmacology allows direct, fast and reversible control of endogenous protein activity, with spatiotemporal resolution set by the illumination method. Here, we combine a photoswitchable allosteric modulator (alloswitch) and two-photon excitation (2PE) using pulsed near-infrared lasers to reversibly silence mGlu5 receptor activity in intact brain tissue. Endogenous receptors can be photoactivated in neurons and astrocytes with pharmacological selectivity and with an axial resolution between 5 and 10 m. Thus, two-photon pharmacology (2PP) using alloswitch allows investigating mGlu5-dependent processes in wild type animals, including synaptic formation and plasticity, and signaling pathways from intracellular organelles.
- organism: mouse
- assay: imaging
- research focus: synaptic & neural circuits
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A photoswitchable GPCR-based opsin for presynaptic silencing
Bryan A. Copits, Raaj Gowrishankar, … Michael R. Bruchas·NeuronPeer-reviewed·May 11, 2021
- A photoswitchable positive allosteric modulator to control the activation of the metabotropic glutamate receptor 5 by light
Anaëlle Dumazer, Roser Borràs‐Tudurí, … Cyril Goudet·Biochemical PharmacologyPeer-reviewed·Jun 24, 2025
- Reversible inhibition of GluN2B-containing NMDA receptors with an in situ red-shifted, photoswitchable antagonist
Chloé Geoffroy, Romain Berraud‐Pache, … Laétitia Mony·ACS Chemical NeurosciencePeer-reviewed·Sep 6, 2024
- In vivo photopharmacology with light-activated opioid drugs
Shannan P. McClain, Xiang Ma, … Matthew R. Banghart·bioRxiv·Feb 2, 2023
- Phototriggered profiling of receptor-proximal proteins in vivo in minutes
Mikiko Takato, Seiji Sakamoto, … Itaru Hamachi·bioRxiv·May 25, 2023
- A 'double-edged' role for type-5 metabotropic glutamate receptors in pain disclosed by light-sensitive drugs
Serena Notartomaso, Nico Antenucci, … Volker Neugebauer·eLifePeer-reviewed·Jul 22, 2024